12/06/2024
10:14 AM | FMR LLC (Filed by)
Tango Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/20/2024
3:24 PM | Tango Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
11/18/2024
6:20 PM | Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
6:24 PM | EcoR1 Capital, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:35 PM | Boxer Capital Management, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
11/07/2024
8:30 PM | Boxer Capital Management, LLC (Reporting)
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
8:40 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/06/2024
6:43 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:23 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:22 AM | Boxer Capital Management, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
10/28/2024
5:59 AM | Boxer Capital Management, LLC (Reporting)
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
8:30 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
8:31 PM | Boxer Capital Management, LLC (Reporting)
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:48 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:50 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
11:03 AM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
8:40 PM | Boxer Capital, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
10/15/2024
6:25 PM | Boxer Asset Management Inc. (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
09/17/2024
3:48 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:43 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
6:19 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
8:01 PM | Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:42 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:45 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Filed by)
| Form SC 13D/A | |
08/30/2024
4:24 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:40 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:53 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
4:59 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:35 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
4:14 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
6:07 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:13 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
4:51 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
4:32 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:15 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
4:41 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
4:48 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately. |
07/23/2024
3:58 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:39 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
7:56 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:14 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:17 PM | Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:21 PM | Peters Malte (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:11 PM | Borisy Alexis (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:13 PM | Ketchum John B (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:16 PM | Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:27 PM | Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
6:18 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:14 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:21 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
8:34 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
8:32 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
8:31 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
8:32 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
3:17 PM | Tango Therapeutics (Filer)
| Form DEF 14A | |
04/17/2024
3:53 PM | Tango Therapeutics (Filer)
| Form PRE 14A | |
04/08/2024
7:46 AM | Southpoint Capital Advisors LP (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
03/18/2024
7:27 AM | Tango Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/18/2024
6:19 AM | Tango Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2024
6:08 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
4:52 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
11:32 AM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
8:04 PM | Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:08 PM | Beckman Daniella (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:09 PM | Barry Douglas (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:14 PM | Tango Therapeutics (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:00 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
